Peter Cornell
Podiatrist · Hillsboro, TXNPI 1235120866
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.5%), education and entertainment — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Pylant Medical at 42.9% of the total. Reporting peaked in 2022 at $1,469 and has fallen 89.2% since, to $159 in 2025.
Across 72 payments — averaging $38.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$1K
- Paratek Pharmaceuticals, Inc.$248
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$186
- Lundbeck LLC$146
- Lilly USA, LLC$140
- AstraZeneca$136
- plus $744 from 17 others
What the payments were for
- Food & beverage$1,58357%
- Education$1,20043%
- Entertainment$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 1 | $1,200 |
| Paratek Pharmaceuticals, Inc. | 9 | $248 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $186 |
| Lundbeck LLC | 8 | $146 |
| Lilly USA, LLC | 7 | $140 |
| AstraZeneca | 2 | $136 |
| Kowa Pharmaceuticals America, Inc. | 7 | $123 |
| Amgen(2 entities) | 6 | $100 |
| Bayer | 1 | $95 |
| Idorsia Pharmaceuticals US Inc | 5 | $93 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $64 |
| Melinta Therapeutics, LLC | 2 | $38 |
| Stryker | 1 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| AbbVie | 1 | $25 |
| Exact Sciences | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Optos, Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Advanced Oxygen Therapy Inc. | 1 | $13 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,800 in reported general payments places this provider in the 55th percentile of 470 podiatrist providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 40 | $920 |
| Diclofenac Sodium | 20 | $322 |
| Terbinafine Hcl | 35 | $297 |
| Gabapentin | 40 | $245 |
| Cephalexin | 57 | $245 |
| Ropinirole Hcl | 39 | $205 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $118 |
| Meloxicam | 23 | $65 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Hillsboro
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
- Richard AdamsGranbury$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.